Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions

Anaerobe

Volumn 30, Issue , 2014, Pages 70-74

  Geirnaert, Annelies ^a   Steyaert, Alix ^a   Eeckhaut, Venessa ^a   Debruyne, Bo ^a   Arends, Jan B A ^a   Van Immerseel, Filip ^a   Boon, Nico ^a   Van de Wiele, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Clostridial cluster IV; Gastric pH; IBD; Invitro; Resistance; Survival

Indexed keywords

BUTYRIC ACID; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; ACETIC ACID DERIVATIVE; ACID; BILE ACID; BUTYRIC ACID DERIVATIVE; FATTY ACID;

ARTICLE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIUM COLONY; BACTERIUM CULTURE; BUTYRICICOCCUS PULLICAECORUM; CENTRIFUGATION; COLONY FORMING UNIT; CONTROLLED STUDY; FATTY ACID ANALYSIS; GASTROINTESTINAL TRACT; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; SIMULATION; CHEMISTRY; CYTOSOL; DRUG EFFECTS; HUMAN; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PANCREAS JUICE; PH; PHYSIOLOGY; SMALL INTESTINE; STOMACH;

ACETATES; ACIDS; BILE ACIDS AND SALTS; BUTYRATES; CYTOSOL; FATTY ACIDS; GRAM-POSITIVE BACTERIA; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINE, SMALL; MICROBIAL VIABILITY; PANCREATIC JUICE; PROBIOTICS; STOMACH;

EID: 84907483703     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2014.08.010     Document Type: Article

References (30)

1. Roediger W.E.W. Utilization of nutrients by isolated epithelial-cells of the rat colon. Gastroenterology 1982, 83:424-429.
2. Hamer H.M., Jonkers D.M.A.E., Bast A., Vanhoutvin S.A.L.W., Fischer M.A.J.G., Kodde A., et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr 2009, 28:88-93.
3. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27:104-119.
4. Van Immerseel F., Ducatelle R., De Vos M., Boon N., Van De Wiele T., Verbeke K., et al. Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. JMed Microbiol 2010, 59:141-143.
5. Walker A.W., Lawley T.D. Therapeutic modulation of intestinal dysbiosis. Pharmacol Res 2013, 69:75-86.
6. Marteau P. Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease. Gut 5 March 2013, 10.1136/gutjnl-2012-304240.
7. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009, 294:1-8.
8. Papa E., Docktor M., Smillie C., Weber S., Preheim S.P., Gevers D., et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One 2012, 7.
9. Eeckhaut V., Machiels K., Perrier C., Romero C., Maes S., Flahou B., et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 22 December 2012, 10.1136/gutjnl-2012-303611.
10. Eeckhaut V., Van Immerseel F., Teirlynck E., Pasmans F., Fievez V., Snauwaert C., et al. Butyricicoccus pullicaecorum gen. nov., sp nov., an anaerobic, butyrate-producing bacterium isolated from the caecal content of a broiler chicken. Int J Syst Evol Microbiol 2008, 58:2799-2802.
11. Miyazaki K., Martin J.C., Marinsek-Logar R., Flint H.J. Degradation and utilization of xylans by the rumen anaerobe Prevotella bryantii (formerly P. ruminicola subsp. brevis) B14. Anaerobe 1997, 3:373-381.
12. Eini A., Sol A., Coppenhagen-Glazer S., Skvirsky Y., Zini A., Bachrach G. Oxygen deprivation affects the antimicrobial action of LL-37 as determined by microplate real-time kinetic measurements under anaerobic conditions. Anaerobe 2013, 22:20-24.
13. Verthe K., Possemiers S., Boon N., Vaneechoutte M., Verstraete W. Stability and activity of an Enterobacter aerogenes - specific bacteriophage under simulated gastro-intestinal conditions. Appl Microbiol Biotechnol 2004, 65:465-472.
14. Jacobsen C.N., Nielsen V.R., Hayford A.E., Moller P.L., Michaelsen K.F., Paerregaard A., et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by invitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 1999, 65:4949-4956.
15. Oomen A.G., Rompelberg C.J.M., Bruil M.A., Dobbe C.J.G., Pereboom D., Sips A. Development of an invitro digestion model for estimating the bioaccessibility of soil contaminants. Arch Environ Contam Toxicol 2003, 44:281-287.
16. Lo Curto A., Pitino I., Mandalari G., Dainty J.R., Faulks R.M., John Wickham M.S. Survival of probiotic lactobacilli in the upper gastrointestinal tract using an invitro gastric model of digestion. Food Microbiol 2011, 28:1359-1366.
17. Martinez R.C.R., Aynaou A.-E., Albrecht S., Schols H.A., De Martinis E.C.P., Zoetendal E.G., et al. Invitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12. Int J Food Microbiol 2011, 149:152-158.
18. Chen C.Y., Nace G.W., Irwin P.L. A6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. JMicrobiol Methods 2003, 55:475-479.
19. De Roy K., Clement L., Thas O., Wang Y.Y., Boon N. Flow cytometry for fast microbial community fingerprinting. Water Res 2012, 46:907-919.
20. De Weirdt R., Possemiers S., Vermeulen G., Moerdijk-Poortvliet T.C.W., Boschker H.T.S., Verstraete W., et al. Human faecal microbiota display variable patterns of glycerol metabolism. Fems Microbiol Ecol 2010, 74:601-611.
21. Oliver J.D. The viable but nonculturable state in bacteria. JMicrobiol 2005, 43:93-100.
22. Northfield T.C., McColl I. Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. Gut 1973, 14:513-518.
23. Kalantzi L., Goumas K., Kalioras V., Abrahamsson B., Dressman J., Reppas C. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006, 23:165-176.
24. Noh D.O., Gilliland S.E. Influence of bile on cellular integrity and beta-galactosidase activity of lactobacillus-acidophilus. JDairy Sci 1993, 76:1253-1259.
25. Kheadr E., Dabour N., Le Lay C., Lacroix C., Fliss I. Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress. Antimicrobial Agents Chemother 2007, 51:169-174.
26. Gilliland S.E., Staley T.E., Bush L.J. Importance of bile tolerance of lactobacillus-acidophilus used as a dietary adjunct. JDairy Sci 1984, 67:3045-3051.
27. Begley M., Gahan C.G.M., Hill C. The interaction between bacteria and bile. Fems Microbiol Rev 2005, 29:625-651.
28. Lopez-Siles M., Khan T.M., Duncan S.H., Harmsen H.J.M., Garcia-Gil L.J., Flint H.J. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol 2012, 78:420-428.
29. Raz I., Gollop N., Polak-Charcon S., Schwartz B. Isolation and characterisation of new putative probiotic bacteria from human colonic flora. Br J Nutr 2007, 97:725-734.
30. Warchol M., Car L., Grill J.P., Schneider F. Metabolic changes in Clostridium absonum ATCC 27555 accompanying induction of epimerization of a primary bile acid. Curr Microbiol 2003, 47:425-430.